Randomized phase II study comparing cisplatin plus pemetrexed plus bevacizumab with carboplatin plus paclitaxel plus bevacizumab in treatment-naive advanced non-squamous non-small cell lung cancer (CLEAR study)

被引：0

作者：

Koyama, R. ^{[1
]}

Udagawa, H. ^{[2
]}

Sugiyama, E. ^{[3
]}

Komuta, K. ^{[4
]}

Mori, M. ^{[5
]}

Yokoyama, T. ^{[6
]}

Sasaki, T. ^{[7
]}

Saito, H. ^{[8
]}

Ishida, H. ^{[9
]}

Nakagawa, H. ^{[10
]}

Sekine, A. ^{[11
]}

Tamura, A. ^{[12
]}

Shingyoji, M. ^{[13
]}

Mizuno, K. ^{[14
]}

Nakamura, A. ^{[15
]}

Kinoshita, A. ^{[16
]}

Yamanaka, T. ^{[17
]}

Goto, K. ^{[2
]}

机构：

[1] Juntendo Univ, Fac Med, Dept Resp Med, Tokyo, Japan

[2] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba, Japan

[3] Natl Canc Ctr, Div Canc Immunol, Kashiwa, Chiba, Japan

[4] Osaka Police Hosp, Dept Resp Med, Osaka, Japan

[5] Natl Hosp Org Toneyama Natl Hosp, Dept Thorac Oncol, Toyonaka, Osaka, Japan

[6] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama, Japan

[7] Asahikawa Med Univ, Resp Ctr, Asahikawa, Hokkaido, Japan

[8] Kanagawa Canc Ctr, Dept Thorac Oncol, Yokohama, Kanagawa, Japan

[9] Showa Univ, Div Med Oncol, Sch Med, Tokyo, Japan

[10] Natl Hosp Org Hirosaki Hosp, Dept Resp Med, Hirosaki, Aomori, Japan

[11] Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan

[12] Natl Hosp Org Tokyo Natl Hosp, Ctr Pulm Dis, Tokyo, Japan

[13] Chiba Canc Ctr, Div Respirol, Chiba, Japan

[14] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pulm Med, Kagoshima, Japan

[15] Sendai Kousei Hosp, Dept Pulm Med, Sendai, Miyagi, Japan

[16] Nagasaki Prefecture Shimabara Hosp, Dept Resp Med, Shimabara, Japan

[17] Yokohama City Univ Med, Dept Biostat, Yokohama, Kanagawa, Japan

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1436P

引用

页数：1

共 50 条

[31] Bevacizumab combined with pemetrexed plus cisplatin followed by maintenance bevacizumab/pemetrexed as first-line treatment of advanced non-squamous non-small cell lung cancer: A single-arm Phase 2 study
Santoro, Armando
Hillerdal, Gunnar N.
Hoeffkenc, Gert
Favaretto, Adolfo
Carrion, Ramon Perez
Visseren-Grul, Carla
Ameryckx, Sophie
Helsberg, Karin
Soldatenkova, Victoria
Bourayou, Nawel
Sorensen, Jens B.
[J]. LUNG CANCER, 2014, 86 (01) : 47 - 53
[32] Bevacizumab plus Weekly Paclitaxel with or Without Carboplatin for Previously-treated Non-squamous Non-Small Cell Lung Cancer
Hata, Akito
Katakami, Nobuyuki
Tanaka, Kosuke
Takeshita, Jumpei
Matsumoto, Takeshi
Monden, Kazuya
Nagata, Kazuma
Masago, Katsuhiro
Kaji, Reiko
Fujita, Shiro
Tachikawa, Ryo
Otsuka, Kyoko
Otsuka, Kojiro
Tomii, Keisuke
[J]. ANTICANCER RESEARCH, 2014, 34 (1A) : 275 - 281
[33] An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia
Chang, John Wen-Cheng
Thongprasert, Sumitra
Wright, Elaine
Tsang, Kenneth
Kim, Heung Tae
Ahn, Myung-Ju
Kim, Joo-Hang
Kang, Jin Hyoung
Kim, Sang-We
Walzer, Stefan
[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 : 13 - 21
[34] NEJ016: Phase II study of carboplatin and weekly paclitaxel plus bevacizumab followed by bevacizumab for highly selected elderly non-squamous non-small cell lung cancer patients
Harada, T.
Miura, S.
Maemondo, M.
Iwashima, A.
Sugawara, S.
Kobayashi, K.
Inoue, A.
Nakagawa, T.
Takiguchi, Y.
Watanabe, H.
Seike, M.
Ishida, T.
Terada, M.
Gemma, A.
Yoshizawa, H.
[J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S617 - S617
[35] Phase II trial of bevacizumab plus pemetrexed and carboplatin in previously untreated advanced nonsquamous non-small cell lung cancer
Dalsania, C. J.
Hageboutros, A.
Harris, E.
Krieger, K.
Vora, C.
Stevenson, J.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[36] A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer
Ciuleanu, T.
Tsai, C. -M.
Tsao, C. -J.
Milanowski, J.
Amoroso, D.
Heo, D. S.
Groen, H. J. M.
Szczesna, A.
Chung, C. -Y.
Chao, T. -Y.
Middleton, G.
Zeaiter, A.
Klingelschmitt, G.
Klughammer, B.
Thatcher, N.
[J]. LUNG CANCER, 2013, 82 (02) : 276 - 281
[37] Phase II study comparing paclitaxel-carboplatin alone with paclitaxel-carboplatin plus bevacizumab in previously untreated Japanese patients with advanced-stage non-squamous non-small cell lung cancer (NSCLC)
Asahina, Hajime
Kunitoh, Hideo
Ichinose, Yukito
Horai, Takeshi
Nishiwaki, Yutaka
Hida, Toyoaki
Yamamoto, Nobuyuki
Kawahara, Masaaki
Saijo, Nagahiro
Fukuoka, Masahiro
[J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S285 - S285
[38] A phase lb study of bavituximab plus carboplatin and pemetrexed in chemotherapy naive stage IV non-squamous non-small cell lung cancer
Grilley-Olson, Juneko
Weiss, Jared
Stinchcombe, Thomas E.
Ivanova, Anastasia
Tynan, Maureen
Shan, Joseph
Socinski, Mark A.
[J]. CANCER RESEARCH, 2012, 72
[39] A Phase Ib Study Of Bavituximab Plus Carboplatin And Pemetrexed In Chemotherapy Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer
Grilley-Olson, J.
Weiss, J.
Stinchcombe, T.
Ivanova, A.
Shan, J.
Villaruz, L.
Socinski, M.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S318 - S318
[40] PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non-Small-Cell Lung Cancer
Patel, Jyoti D.
Socinski, Mark A.
Garon, Edward B.
Reynolds, Craig H.
Spigel, David R.
Olsen, Mark R.
Hermann, Robert C.
Jotte, Robert M.
Beck, Thaddeus
Richards, Donald A.
Guba, Susan C.
Liu, Jingyi
Frimodt-Moller, Bente
John, William J.
Obasaju, Coleman K.
Pennella, Eduardo J.
Bonomi, Philip
Govindan, Ramaswamy
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4349 - U77

← 1 2 3 4 5 →